BCRX

BioCryst Pharmaceuticals News

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
BioCryst Pharmaceuticals Inc BCRX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.52 3.12% 17.17 19:27:59
Open Price Low Price High Price Close Price Prev Close
16.64 16.64 17.4264 16.99 16.65
more quote information »

Recent News

Date Time Source Heading
6/23/20217:00IHNWFeaturedThe Emerging Growth / Investors Hub Conference is Today!  Register Now
6/23/20218:30IHNWFeaturedRed Metal Resources Private Placement Oversubscribed with Lead by AlphaNorth Asset Management as Outlook for Copper Soars
6/23/20218:45IHNWFeaturedEsports Technologies Files Patent for Live Streaming Wagering Technology
6/23/20219:00IHNWFeaturedIntegrated Ventures And Wattum Management Partner To Secure 12 Month Purchase Deal For 2,400 WhatsMiners
6/16/202107:24SEEKBioCryst's Orladeyo application accepted in Israel for..
6/16/202107:00GLOBEBioCryst Announces Acceptance and Accelerated Review of the..
6/03/202107:08EDGARCurrent Report Filing (8-k)
6/03/202107:00GLOBEBioCryst Launches ORLADEYO™ (berotralstat) in Germany
6/01/202116:28EDGARStatement of Changes in Beneficial Ownership (4)
6/01/202116:24EDGARStatement of Changes in Beneficial Ownership (4)
6/01/202116:16EDGARStatement of Changes in Beneficial Ownership (4)
5/28/202116:31EDGARSecurities Registration: Employee Benefit Plan (s-8)
5/27/202116:42EDGARStatement of Changes in Beneficial Ownership (4)
5/27/202116:36EDGARStatement of Changes in Beneficial Ownership (4)
5/27/202116:22EDGARStatement of Changes in Beneficial Ownership (4)
5/27/202116:18EDGARStatement of Changes in Beneficial Ownership (4)
5/27/202116:12EDGARStatement of Changes in Beneficial Ownership (4)
5/26/202116:27EDGARCurrent Report Filing (8-k)
5/26/202116:12EDGARStatement of Changes in Beneficial Ownership (4)
5/26/202107:00GLOBEBioCryst to Present at Upcoming Investor Conferences
5/13/202116:43EDGARStatement of Changes in Beneficial Ownership (4)
5/12/202117:02EDGARStatement of Changes in Beneficial Ownership (4)
5/12/202109:46EDGARCurrent Report Filing (8-k)
5/12/202109:34SEEKUK's MHRA grants marketing authorization to BioCryst's..
5/12/202109:25GLOBEBioCryst Receives UK Approval of ORLADEYO™ (berotralstat),..
5/07/202116:20EDGARQuarterly Report (10-q)
5/06/202116:00SEEKBioCryst shares surge 21% on Evercore upgrade, revenue beat
5/06/202107:48SEEKBioCryst shares rise on ORLADEYO driven Q1 revenue beat
5/06/202107:10EDGARCurrent Report Filing (8-k)
5/06/202107:05SEEKBioCryst Pharmaceuticals EPS misses by $0.08, beats on..
5/06/202107:00GLOBEBioCryst Reports First Quarter 2021 Financial Results and..
5/05/202107:00GLOBEBioCryst to Present at Upcoming Investor Conferences
4/30/202110:58EDGARCurrent Report Filing (8-k)
4/30/202109:29SEEKBioCryst gets European Commission approval of ORLADEYO
4/30/202109:21GLOBEBioCryst Receives European Commission Approval of ORLADEYO™..
4/22/202107:00GLOBEBioCryst to Report First Quarter 2021 Financial Results on..
4/19/202113:24EDGARSec Staff Action/letter (sec Staff)
4/14/202109:03SEEKBioCryst gets approval of Japanese NHI price listing of..
4/14/202108:21EDGARCurrent Report Filing (8-k)
4/14/202108:15GLOBEBioCryst Announces Approval of Japanese NHI Price Listing of..
4/13/202116:16EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
4/13/202116:12EDGARProxy Statement (definitive) (def 14a)
4/12/202115:33SEEKBioCryst slides as State Street cuts stake
4/12/202109:37EDGARAmended Statement of Ownership (sc 13g/a)
4/07/202107:00GLOBEBioCryst to Present at 20th Annual Needham Virtual..
3/26/202114:03EDGARCurrent Report Filing (8-k)
3/24/202112:16TRMNBioCryst: Sometimes Good News Isn’t Good Enough
3/23/202109:31SEEKBioCryst’s oral therapy reaches pivotal studies in..
3/22/202116:20EDGARStatement of Changes in Beneficial Ownership (4)
3/22/202108:08EDGARCurrent Report Filing (8-k)
3/22/202108:00GLOBEBioCryst’s Oral Factor D Inhibitor, BCX9930, Advancing to..
3/19/202107:10SEEKBioCryst appoints Helen Thackray chief research and..
3/19/202107:00GLOBEBioCryst Appoints Helen Thackray, M.D., as Chief Research..
3/15/202107:00GLOBEBioCryst to Host Virtual R&D Day on March 22, 2021
See more news about this stock »


Your Recent History
NASDAQ
BCRX
BioCryst P..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.